{"id":"https://openalex.org/W2160328215","doi":"https://doi.org/10.1158/0008-5472.can-10-4076","title":"Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy","display_name":"Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy","publication_year":2011,"publication_date":"2011-06-13","ids":{"openalex":"https://openalex.org/W2160328215","doi":"https://doi.org/10.1158/0008-5472.can-10-4076","mag":"2160328215","pmid":"https://pubmed.ncbi.nlm.nih.gov/21670078"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-10-4076","doi":"https://doi.org/10.1158/0008-5472.can-10-4076","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-10-4076","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/71/15/5235/2655372/5235.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/cancerres/article-pdf/71/15/5235/2655372/5235.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006674728","display_name":"Ryan B. Rountree","orcid":"https://orcid.org/0009-0000-3426-2605","observed_orcids":["https://orcid.org/0009-0000-3426-2605"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ryan B. Rountree","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055785154","display_name":"Stefanie J. Mandl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefanie J. Mandl","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009511044","display_name":"James M. Nachtwey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James M. Nachtwey","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051579792","display_name":"Katie Dalpozzo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katie Dalpozzo","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082826484","display_name":"Lisa Do","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Do","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041269133","display_name":"John R. Lombardo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John R. Lombardo","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029705946","display_name":"Peter L. Schoonmaker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter L. Schoonmaker","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087929718","display_name":"Kay Brinkmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kay Brinkmann","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055083900","display_name":"Ulrike Dirmeier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ulrike Dirmeier","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090532560","display_name":"Reiner Laus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reiner Laus","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080278046","display_name":"Alain X. Delcayre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alain Delcayre","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Research and Development, BN ImmunoTherapeutics, Mountain View, California; and 2Bavarian Nordic GmbH, Frauenhoferstrasse 13, Martinsried, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5006674728"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.3412,"has_fulltext":true,"cited_by_count":163,"citation_normalized_percentile":{"value":0.95138677,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"71","issue":"15","first_page":"5235","last_page":"5244"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10773","display_name":"Extracellular vesicles in disease","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11767","display_name":"Poxvirus research and outbreaks","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exosome-targeting","display_name":"exosome targeting","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.6840000152587891},{"id":"https://openalex.org/keywords/modified-vaccinia-ankara","display_name":"modified vaccinia Ankara","score":0.7440000176429749},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.6700000166893005},{"id":"https://openalex.org/keywords/prostate-specific-antigen","display_name":"prostate-specific antigen","score":0.9750000238418579},{"id":"https://openalex.org/keywords/prostatic-acid-phosphatase","display_name":"prostatic acid phosphatase","score":1.0},{"id":"https://openalex.org/keywords/antigen-immunogenicity","display_name":"antigen immunogenicity","score":0.9259999990463257},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.8050000071525574},{"id":"https://openalex.org/keywords/tumor-rejection","display_name":"tumor rejection","score":0.49900001287460327},{"id":"https://openalex.org/keywords/vaccine-immunotherapy","display_name":"vaccine immunotherapy","score":0.30399999022483826}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.8420694470405579},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.7244718074798584},{"id":"https://openalex.org/C2776490512","wikidata":"https://www.wikidata.org/wiki/Q21151790","display_name":"Prostatic acid phosphatase","level":4,"score":0.6822126507759094},{"id":"https://openalex.org/C2781261824","wikidata":"https://www.wikidata.org/wiki/Q903634","display_name":"Exosome","level":5,"score":0.6474561095237732},{"id":"https://openalex.org/C2778378633","wikidata":"https://www.wikidata.org/wiki/Q2378309","display_name":"Cancer vaccine","level":4,"score":0.4847797751426697},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4819183647632599},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4612520933151245},{"id":"https://openalex.org/C2781356689","wikidata":"https://www.wikidata.org/wiki/Q1986297","display_name":"Vaccinia","level":4,"score":0.44498211145401},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4380439221858978},{"id":"https://openalex.org/C2779026604","wikidata":"https://www.wikidata.org/wiki/Q4774742","display_name":"Antigenicity","level":3,"score":0.4323018789291382},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4249612092971802},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.4232713282108307},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.4140568673610687},{"id":"https://openalex.org/C20518536","wikidata":"https://www.wikidata.org/wiki/Q6840469","display_name":"Microvesicles","level":4,"score":0.4083392024040222},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4073725640773773},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4012015461921692},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.37033769488334656},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3456842303276062},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.17894119024276733},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000135","descriptor_name":"Acid Phosphatase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000912","descriptor_name":"Antibodies, Neoplasm","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000954","descriptor_name":"Antigens, Surface","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008894","descriptor_name":"Milk Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008894","descriptor_name":"Milk Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D014613","descriptor_name":"Vaccines, Attenuated","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014616","descriptor_name":"Vaccinia virus","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016233","descriptor_name":"Immunotherapy, Active","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017027","descriptor_name":"Protein Tyrosine Phosphatases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D017434","descriptor_name":"Protein Structure, Tertiary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018417","descriptor_name":"Th1 Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055354","descriptor_name":"Exosomes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.can-10-4076","doi":"https://doi.org/10.1158/0008-5472.can-10-4076","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-10-4076","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/71/15/5235/2655372/5235.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:21670078","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21670078","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.can-10-4076","doi":"https://doi.org/10.1158/0008-5472.can-10-4076","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-10-4076","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/71/15/5235/2655372/5235.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2160328215.pdf","grobid_xml":"https://content.openalex.org/works/W2160328215.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W163907105","https://openalex.org/W1415896497","https://openalex.org/W1930739105","https://openalex.org/W1982895831","https://openalex.org/W1986321004","https://openalex.org/W2020032658","https://openalex.org/W2024746932","https://openalex.org/W2033598310","https://openalex.org/W2073023385","https://openalex.org/W2078511497","https://openalex.org/W2083995483","https://openalex.org/W2097585139","https://openalex.org/W2098574945","https://openalex.org/W2103959341","https://openalex.org/W2112813954","https://openalex.org/W2124589099","https://openalex.org/W2155846302","https://openalex.org/W2157154128","https://openalex.org/W2169258216","https://openalex.org/W2225416664","https://openalex.org/W6670005920"],"related_works":["https://openalex.org/W1992571832","https://openalex.org/W2498341864","https://openalex.org/W3026111010","https://openalex.org/W2529776520","https://openalex.org/W2119454135","https://openalex.org/W2044896831","https://openalex.org/W7223282772","https://openalex.org/W2207191728","https://openalex.org/W4229769241","https://openalex.org/W2165085849"],"abstract_inverted_index":{"MVA-BN-PRO":[0,107,210,244],"(BN":[1],"ImmunoTherapeutics)":[2],"is":[3,28,76,234],"a":[4,132,185,192,214,221,235],"candidate":[5],"immunotherapy":[6],"product":[7],"for":[8,158,238],"the":[9,31,48,80,83,87,97,121,136,168,202,240],"treatment":[10,164,198,208],"of":[11,50,86,99,106,126,170,188,204,216,243],"prostate":[12],"cancer.":[13],"It":[14],"encodes":[15],"2":[16,103],"tumor-associated":[17],"antigens,":[18],"prostate-specific":[19],"antigen":[20,81,230],"(PSA),":[21],"and":[22,27,101,147,211],"prostatic":[23],"acid":[24],"phosphatase":[25],"(PAP),":[26],"derived":[29],"from":[30],"highly":[32],"attenuated":[33],"modified":[34],"vaccinia":[35],"Ankara":[36],"(MVA)":[37],"virus":[38],"stock":[39],"known":[40],"as":[41],"MVA-BN.":[42],"Past":[43],"work":[44],"has":[45],"shown":[46],"that":[47,150,228],"immunogenicity":[49,98],"antigens":[51],"can":[52],"be":[53],"improved":[54,217],"by":[55,70,78],"targeting":[56,75,94,110,229],"their":[57],"localization":[58,231],"to":[59,65,82,117,131,153,232],"exosomes,":[60,118],"which":[61],"are":[62],"small,":[63],"50-":[64],"100-nm":[66],"diameter":[67],"vesicles":[68],"secreted":[69],"most":[71],"cell":[72],"types.":[73],"Exosome":[74],"achieved":[77],"fusing":[79],"C1C2":[84],"domain":[85],"lactadherin":[88],"protein.":[89],"To":[90],"test":[91],"whether":[92],"exosome":[93],"would":[95],"improve":[96],"PSA":[100,112,205],"PAP,":[102],"additional":[104],"versions":[105],"were":[108,151],"produced,":[109],"either":[111],"(MVA-BN-PSA-C1C2)":[113],"or":[114],"PAP":[115],"(MVA-BN-PAP-C1C2)":[116],"while":[119],"leaving":[120],"second":[122],"transgene":[123],"untargeted.":[124],"Treatment":[125],"mice":[127,159,177],"with":[128,161,165,176,179,199,207,209],"MVA-BN-PAP-C1C2":[129,166],"led":[130],"striking":[133],"increase":[134],"in":[135,191,213,220,245],"immune":[137],"response":[138],"against":[139],"PAP.":[140],"Anti-PAP":[141],"antibody":[142],"titers":[143],"developed":[144],"more":[145],"rapidly":[146],"reached":[148],"levels":[149],"10-":[152],"100-fold":[154],"higher":[155],"than":[156],"those":[157],"treated":[160,178],"MVA-BN-PRO.":[162,180],"Furthermore,":[163],"increased":[167,201],"frequency":[169,187],"PAP-specific":[171],"T":[172],"cells":[173],"5-fold":[174],"compared":[175,206],"These":[181,225],"improvements":[182],"translated":[183],"into":[184],"greater":[186],"tumor":[189,195,223],"rejection":[190],"PAP-expressing":[193],"solid":[194],"model.":[196,224],"Likewise,":[197],"MVA-BN-PSA-C1C2":[200],"antigenicity":[203],"resulted":[212],"trend":[215],"antitumor":[218],"efficacy":[219],"PSA-expressing":[222],"experiments":[226],"confirm":[227],"exosomes":[233],"viable":[236],"approach":[237],"improving":[239],"therapeutic":[241],"potential":[242],"humans.":[246]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":19},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}